Abruzzo-Erickson syndrome

Abruzzo-Erickson syndrome is an extremely rare genetic disorder first described in 1977 by Abruzzo and Erickson. It is characterized by a distinctive combination of congenital anomalies that primarily affect the eyes, ears, and other craniofacial structures. Key clinical features include coloboma of the iris or retina (a gap or defect in eye structures), cleft palate, hearing loss (typically sensorineural), short stature, and radial synostosis (fusion of the radius bone in the forearm). Some patients may also present with hypospadias in males and other skeletal abnormalities. The syndrome affects multiple body systems, most notably the ocular, auditory, craniofacial, and musculoskeletal systems. The combination of eye colobomas with cleft palate and hearing impairment can significantly impact a child's development, including speech and language acquisition. Intellectual development is generally reported as normal, though developmental support may be needed due to sensory impairments. There is currently no cure or specific targeted therapy for Abruzzo-Erickson syndrome. Management is symptomatic and supportive, involving a multidisciplinary team. This may include surgical repair of cleft palate, hearing aids or cochlear implants for hearing loss, ophthalmologic management of colobomas, and orthopedic intervention for skeletal anomalies. Early intervention services for speech and developmental support are important components of care. Only a very small number of cases have been reported in the medical literature, making it one of the rarest described genetic conditions.

Common questions about Abruzzo-Erickson syndrome